Immunological changes in patients with community-acquired pneumonia with concomitant coronary artery disease during treatment with Simvastatin
(cellular and humoral immunity, mucosal immunity, the complement system, and so on). With features of immune system in the elderly people related some of clinical problems: hypersensitivity to non- and intra-hospital infections, subacute infection that increases concomitant diseases, especially car...
Saved in:
| Main Authors: | V. V. Syvolap, L. O. Kurilets, L. V. Lukashenko, A. O. Yarosh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2016-03-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/69210/65151 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictors of a prolonged course of community-acquired pneumonia
by: V. V. Syvolap, et al.
Published: (2017-04-01) -
Effect of Simvastatin on the spectrum of blood plasma fat acids change in the patients with ischemia heart disease
by: V. V. Novitsky, et al.
Published: (2008-09-01) -
ANTIISCHEMIC AND ANTIARRHYTHMIC EFFECTS OF SIMVASTATIN IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2013-12-01) -
Features of the left ventricle diastolic function in patients with community acquired pneumonia
by: V. V. Syvolap, et al.
Published: (2014-04-01) -
Antioxidant effects of simvastatin in patients with coronary heart disease and dyslipidemia
by: N. E. Artamoshina, et al.
Published: (2012-12-01)